These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 31904143)

  • 1. Triptolide inhibits CD133
    Acikgoz E; Tatar C; Oktem G
    J Cell Biochem; 2020 Jun; 121(5-6):3313-3324. PubMed ID: 31904143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment.
    Wang X; Zheng M; Fei F; Li C; Du J; Liu K; Li Y; Zhang S
    Med Oncol; 2019 Aug; 36(9):82. PubMed ID: 31407170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.
    Liu L; Salnikov AV; Bauer N; Aleksandrowicz E; Labsch S; Nwaeburu C; Mattern J; Gladkich J; Schemmer P; Werner J; Herr I
    Int J Cancer; 2014 May; 134(10):2489-503. PubMed ID: 24615157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
    Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Triptolide Loaded HER2-Targeted Nano-Drug Delivery System Significantly Suppressed the Proliferation of HER2-Positive and BRAF Mutant Colon Cancer.
    Yalikong A; Li XQ; Zhou PH; Qi ZP; Li B; Cai SL; Zhong YS
    Int J Nanomedicine; 2021; 16():2323-2335. PubMed ID: 33776436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial-mesenchymal transition.
    Deng QD; Lei XP; Zhong YH; Chen MS; Ke YY; Li Z; Chen J; Huang LJ; Zhang Y; Liang L; Lin ZX; Liu Q; Li SP; Yu XY
    Acta Pharmacol Sin; 2021 Sep; 42(9):1486-1497. PubMed ID: 33893396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triptolide inhibits benign prostatic epithelium viability and migration and induces apoptosis via upregulation of microRNA-218.
    Yao C; Li H; Zhang W
    Int J Immunopathol Pharmacol; 2018; 32():2058738418812349. PubMed ID: 30453799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Chemical Proteomics Reveals Triptolide Selectively Inhibits HCT116 Human Colon Cancer Cell Viability and Migration Through Binding to Peroxiredoxin 1 and Annexin A1.
    Song F; Li J; Shi Q; Wong YK; Liu D; Lin Q; Wang J; Chen X
    Adv Biol (Weinh); 2024 Oct; 8(10):e2300452. PubMed ID: 37794608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide inhibits the proliferation and migration of medulloblastoma Daoy cells by upregulation of microRNA-138.
    Zhang H; Li H; Liu Z; Ge A; Guo E; Liu S; Chen Z
    J Cell Biochem; 2018 Dec; 119(12):9866-9877. PubMed ID: 30156009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo.
    Liu Y; Xiao E; Yuan L; Li G
    DNA Cell Biol; 2014 Jul; 33(7):418-25. PubMed ID: 24720675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase.
    Lin Y; Peng N; Li J; Zhuang H; Hua ZC
    Mol Cancer; 2013 Jun; 12():54. PubMed ID: 23758884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F.
    Oliveira A; Beyer G; Chugh R; Skube SJ; Majumder K; Banerjee S; Sangwan V; Li L; Dawra R; Subramanian S; Saluja A; Dudeja V
    Lab Invest; 2015 Jun; 95(6):648-659. PubMed ID: 25893635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma.
    Modi SJ; Kulkarni VM
    Eur J Med Chem; 2020 Dec; 207():112851. PubMed ID: 33002846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptolide decreases tumor-associated macrophages infiltration and M2 polarization to remodel colon cancer immune microenvironment via inhibiting tumor-derived CXCL12.
    Jiang X; Cao G; Gao G; Wang W; Zhao J; Gao C
    J Cell Physiol; 2021 Jan; 236(1):193-204. PubMed ID: 32495392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.
    Li H; Takai N; Yuge A; Furukawa Y; Tsuno A; Tsukamoto Y; Kong S; Moriyama M; Narahara H
    Cancer Lett; 2010 Nov; 297(2):198-206. PubMed ID: 20547442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excessive hyaluronan production promotes acquisition of cancer stem cell signatures through the coordinated regulation of Twist and the transforming growth factor β (TGF-β)-Snail signaling axis.
    Chanmee T; Ontong P; Mochizuki N; Kongtawelert P; Konno K; Itano N
    J Biol Chem; 2014 Sep; 289(38):26038-26056. PubMed ID: 25077968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enrichment of cancer stem-like cells by the induction of epithelial-mesenchymal transition using lentiviral vector carrying E-cadherin shRNA in HT29 cell line.
    Saltanatpour Z; Johari B; Alizadeh A; Lotfinia M; Majidzadeh-A K; Nikbin B; Kadivar M
    J Cell Physiol; 2019 Dec; 234(12):22935-22946. PubMed ID: 31111504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide inhibits the multidrug resistance in prostate cancer cells via the downregulation of MDR1 expression.
    Guo Q; Nan XX; Yang JR; Yi L; Liang BL; Wei YB; Zhu N; Hu SB; Zhang H; Luo Y; Xu YF
    Neoplasma; 2013; 60(6):598-604. PubMed ID: 23906293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway.
    Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M
    Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.